Webinar Date/Time: Monday, November 13, 2023 at 11am ET | 8am PT | 4pm BST
Early-stage scenario planning in clinical development is crucial yet challenging due to resource constraints across cross-functional teams involved in the planning process. Join us to learn how analytical tools powered by benchmarks can help drive more informed, value-maximizing decisions.
Register Free: https://www.pharmexec.com/pe/integrated-scenario-planning
Event Overview:
As complexity in the biopharmaceutical industry grows, making optimal clinical development decisions has become increasingly difficult and more important than ever. Companies must effectively integrate a growing number of factors in real-time to optimize spend and bring drugs to market efficiently. This is challenging as it requires cross-functional collaboration, an iterative process, and real-time analysis.
Please join us for a webinar where we discuss reasons why integrating multiple perspectives is crucial for effective clinical development planning. We will also showcase how sophisticated analytical software tools, powered by clinical benchmarks, optimize clinical development planning.
Three key take-aways
Speakers:
David Wolter
Vice President, IQVIA Commercial Consulting
IQVIA
David Wolter is a vice president in IQVIA’s Commercial Solutions group. He has more than 18 years of experience in management consulting and modeling system development, and is the co-lead of the US Corporate & Portfolio Strategy Center of Excellence. His past work has included product valuations, the design and development of forecasting models and web-based tools, analogue analyses, and decision-analysis/strategy projects. David has an MBA from Stanford GSB, a MS in Accounting from DePaul University, and a BA in Economics from Amherst College.
Rob Narayana
Associate Principal, Commercial Solutions
IQVIA
Rob Narayana is an associate principal in IQVIA’s Commercial Solutions group. He has more than 7 years of experience building software that solves big data, visualization, and advanced analytics problems in pharma. His past work spans across clinical development planning, forecasting, market access, and commercial launch strategy. Prior to IQVIA, Rob advised healthcare companies on mergers and acquisitions in investment banking. Rob has a BS in Business Administration from University of Pittsburgh.
Register Free: https://www.pharmexec.com/pe/integrated-scenario-planning
Cell and Gene Therapy Check-in 2024
January 18th 2024Fran Gregory, VP of Emerging Therapies, Cardinal Health discusses her career, how both CAR-T therapies and personalization have been gaining momentum and what kind of progress we expect to see from them, some of the biggest hurdles facing their section of the industry, the importance of patient advocacy and so much more.